Production of pentameric cholera toxin B subunit in Escherichia coli

Avicenna Journal of Medical Biotechnology

Volumn 4, Issue 2, 2012, Pages 89-94

  Dakterzada, Farida ^a   Mobarez, Ashraf Mohabati ^a   Roudkenar, Mehryar Habibi ^b   Forouzandeh, Mehdi ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

Author keywords

Cholera toxin B Subunit; Enzyme linked immunosorbent assay; Western blotting

Indexed keywords

CHOLERA TOXIN B SUBUNIT; GANGLIOSIDE GM1;

ARTICLE; ESCHERICHIA COLI; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FOLDING; PROTEIN PURIFICATION; WESTERN BLOTTING;

EID: 84862023905     PISSN: 20082835     EISSN: 20084625     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wachsmuth IK, Blake PA, Olsvik O, eds. Cholera 2009. Weekly Epidemiol Rec 2010;85:293-308.
2. Spangler DD. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev 1992;56(4):622-647.
3. Jertborn M, Nordstrom I, Kilander A, Czerkinsky C, Holmgren J. Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humans. Infect Immun 2001;69(6):4125-4128.
4. Bergquist C, Johansson EL, Lagergard T, Holmgren J, Rudin A. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun 1997;65(7):2676-2684.
5. Harakuni T, Sugawa H, Komesu A, Tadano M, Arakawa T. Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induces systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems. Infect Immun 2005;73(9):5654-5665.
6. Gong Z, Long X, Pan L, Le Y, Liu Q, Wang S, et al. Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli. Protein Expr Purif 2009;66(2): 191-197.
7. Anjuere F, George-Chandy A, Audant F, Rousseau D, Holmgren J, Czerkinsky C. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses. J Immunol 2003;170(3):1586-1592.
8. Gong Z, Jin Y, Zhang Y. Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm. Vaccine 2007;25(8):1444-1451.
9. Zeighami H, Sattari M, Rezayat M. Cloning and expression of a cholera toxin beta subunit in Escherichia coli. Ann Microbiol 2010;60(3):451-454.
10. Areas AP, Oliveira ML, Ramos CR, Sbrogio-Almeida ME, Raw I, Ho PL. Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6XHis-tagged protein in Escherichia coli. Protein Expr Purif 2002;25(3):481-487.
11. Arzanlou M, Rezaee A, Shahrokhi N, Hossini AZ, Yasuda Y, Tochikubo K, et al. Expression of cholera toxin B subunit in Saccharomyces cerevisiae. Ann Microbiol 2005;55:145-150.
12. Daniell H, Lee SB, Panchal T, Wiebe PO. Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. J Mol Biol 2001;311(5):1001-1009.
13. Kim YS, Kim MY, Kim TG, Yang MS. Expression and assembly of cholera toxin B subunit (CTB) in transgenic carrot (Daucus carota L.). Mol Biotechnol 2009;41(1):8-14.
14. Gong ZH, Jin HQ, Jin YF, Zhang YZ. Expression of cholera toxin B subunit and assembly as functional oligomers in silkworm. J Biochem Mol Biol 2005;38(6):717-724.
15. Slos P, Dutot P, Reymund J, Kleinpeter P, Prozzi D, Kieny MP, et al. Production of cholera toxin B subunit in Lactobacillus. FEMS Microbiol Lett 1998;169(1):29-36.
16. Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual. 3rd ed. New York: Cold Spring Harbor Laboratory Press;2001.
17. Miyata T, Harakuni T, Tsuboi T, Sattabongkot J, Kohama H, Tachibana M, et al. Plasmodium vivax ookinete surface protein Pvs25 linked to cholera toxin B subunit induces potent transmission-blocking immunity by intranasal as well as subcutaneous immunization. Infect Immun 2010;78(9):3773-3782.
18. L'Hoir C, Renard A, Martial JA. Expression in Escherichia coli of two mutated genes encoding the cholera toxin B subunit. Gene 1990;89(1):47-52.
19. Goto N, Maeyama J, Yasuda Y, Isaka M, Matano K, Kozuka S, et al. Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant. Vaccine 2000;18 (20):2164-2171.
20. Sanchez J, Holmgren J. Recombinant system for over expression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development. Proc Natl Acad Sci USA 1989;86(2):481-485.
21. Singh SM, Panda AK. Solubilization and refolding of bacterial inclusion body proteins. J Biosci Bioeng 2005;99(4):303-310.